45 Boulevard Marcel Pagnol Batiment GrasseBiotech Grasse, Provence-Alpes-Côte d'Azur, 06130 FranceBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery / cardiotoxicity / dermatology / ophthalmology - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."

20 Chemin des Yvelines Peymeinade, 06530 FranceCorstrate is a business development consultancy specialized in life sciences, supporting CROs, CDMOs, biotech and pharma service providers, and technology vendors. We help companies generate qualified leads, acquire new clients, and build effective commercial strategies across the US, UK, Asia and European markets.

Les espaces de Sophia - bat I 80 route des lucioles VALBONNE, VALBONNE, 06560 FranceBy integrating in vitro, ex vivo, and in vivo electrophysiological assays within a single platform, E-PHY-SCIENCE provides a uniquely comprehensive suite of studies. Our assays enable the identification of functional abnormalities across diverse genetic and pharmacological models of CNS diseases, and the assessment of how new therapeutics modulate neuronal, synaptic, and network activity. These experiments generate high-quality translational data and robust functional readouts — some of which can serve as potential biomarkers of efficacy or disease progression. Whether at the scale of whole-animal recordings or single-channel analyses, our team addresses the full spectrum of electrophysiological needs, offering deep mechanistic insight and actionable decision-making support for drug development.

2400 route des colles Biot, Other (Non U.S.), 06410 FranceBy integrating in vitro, ex vivo, and in vivo electrophysiological assays within a single platform, E-PHY-SCIENCE provides a uniquely comprehensive suite of studies. Our assays enable the identification of functional abnormalities across diverse genetic and pharmacological models of CNS diseases, and the assessment of how new therapeutics modulate neuronal, synaptic, and network activity. These experiments generate high-quality translational data and robust functional readouts — some of which can serve as potential biomarkers of efficacy or disease progression. Whether at the scale of whole-animal recordings or single-channel analyses, our team addresses the full spectrum of electrophysiological needs, offering deep mechanistic insight and actionable decision-making support for drug development.

Les espaces de Sophia - bat I 80 route des lucioles VALBONNE, 06560 FranceBy integrating in vitro, ex vivo, and in vivo electrophysiological assays within a single platform, E-PHY-SCIENCE provides a uniquely comprehensive suite of studies. Our assays enable the identification of functional abnormalities across diverse genetic and pharmacological models of CNS diseases, and the assessment of how new therapeutics modulate neuronal, synaptic, and network activity. These experiments generate high-quality translational data and robust functional readouts — some of which can serve as potential biomarkers of efficacy or disease progression. Whether at the scale of whole-animal recordings or single-channel analyses, our team addresses the full spectrum of electrophysiological needs, offering deep mechanistic insight and actionable decision-making support for drug development.

263, Via Nova Pole d'Excellence Jean-Louis FREJUS, Provence-Alpes-Cote-d'Azur, 83600 FranceFrance Tissue Bank (FTB) work with biobanks providing high-quality human tissue samples and associated health data (pathology, clinical, biological) for biomedical research. We support pharmaceutical companies, biotech firms, CROs, and academic research teams in their R&D projects in oncology and inflammatory diseases, ensuring: 🔬 Certified, traceable human biospecimens, 📊 Anonimized, multimodal health data integrated within a secure, GDPR-compliant data warehouse, 🤝 Customized project management, from biosample selection to cohort design and data integration, ⚙️ Full ethical and regulatory compliance (CNIL, GDPR, Jardé law). FTB accelerates translational and clinical research by providing reliable, structured, and exploitable biospecimens and health datasets tailored to your scientific and industrial needs.

263 Via NOVA Pole d'Excellence Jean-Louis Fréjus, Provence-Alpes-Côte d'Azur, 83600 FranceFrance Tissue Bank (FTB) work with biobanks providing high-quality human tissue samples and associated health data (pathology, clinical, biological) for biomedical research. We support pharmaceutical companies, biotech firms, CROs, and academic research teams in their R&D projects in oncology and inflammatory diseases, ensuring: 🔬 Certified, traceable human biospecimens, 📊 Anonimized, multimodal health data integrated within a secure, GDPR-compliant data warehouse, 🤝 Customized project management, from biosample selection to cohort design and data integration, ⚙️ Full ethical and regulatory compliance (CNIL, GDPR, Jardé law). FTB accelerates translational and clinical research by providing reliable, structured, and exploitable biospecimens and health datasets tailored to your scientific and industrial needs.

Les Templiers - 2400, route des Colles Sophia Antipolis, Biot 06410 FranceGalderma focuses on the drug development for the therapeutic areas of skin diseases as well as an array of genome analysis, screening, imaging, and pharmacokinetic/pharmakodynamic services.

25 Via Maestri del Lavoro P.i.p. Roata Raffo, Piemonte, 12022 ItalyGEM FORLAB is an R&D service provider devoted to supporting companies belonging to the life science field. GEM FORLAB is the partner of choice for companies which require to manage and solve complex problems according to regolatory requirements. Its strenght is based on scientific and technological platforms, quality system, competences, flexibility and versatility in meeting costumer's needs. A wide range of services, provided in compliance with GLP and GCP, is available to support R&D programs of NCEs, NBEs and PPP from preclinical to advanced clinical phases (I-III).

Via Maestri del Lavoro, 25 Busca, 12022 ItalyGEM FORLAB is an R&D service provider devoted to supporting companies belonging to the life science field. GEM FORLAB is the partner of choice for companies which require to manage and solve complex problems according to regolatory requirements. Its strenght is based on scientific and technological platforms, quality system, competences, flexibility and versatility in meeting costumer's needs. A wide range of services, provided in compliance with GLP and GCP, is available to support R&D programs of NCEs, NBEs and PPP from preclinical to advanced clinical phases (I-III).

Les Nertières Allée Hector Pintus La Gaude, 06610 FranceIris Pharma is a world-leading Contract Research Organization (CRO) offering preclinical ophthalmology research services. Iris Pharma works hand-in-hand with customers and has helped bring more than 70 ocular drugs and medical devices to international markets to date. The company is able to do this as efficiently as possible by maintaining a global view of the development process and by bringing personalized advice. Iris Pharma indeed addresses all ophthalmology challenges by offering programs and study designs that perfectly suit the needs of customers: therapeutic value assessment, full preclinical regulatory package, product value creation or à la carte studies. Compliance with GLP requirements; CIR agreement.

ZI Les Nertières, Allée Hector Pintus F-06610 La Gaude FranceIris Pharma is a world-leading Contract Research Organization (CRO) offering preclinical ophthalmology research services. Iris Pharma works hand-in-hand with customers and has helped bring more than 70 ocular drugs and medical devices to international markets to date. The company is able to do this as efficiently as possible by maintaining a global view of the development process and by bringing personalized advice. Iris Pharma indeed addresses all ophthalmology challenges by offering programs and study designs that perfectly suit the needs of customers: therapeutic value assessment, full preclinical regulatory package, product value creation or à la carte studies. Compliance with GLP requirements; CIR agreement.

Carros, ItalyLHS Laboratoire specialize in private label manufacturing.

2400 Route des Colles Biot, Provence-Alpes-Côte d'Azur, 06410 FranceNUVISAN IN A NUTSHELL Introduction - NUVISAN is a fully integrated contract research organization "from molecule to patient" - Nearly four decades as one of Germany’s first CROs (est. 1979) - Capabilities distributed across five locations in Germany and France - Balanced client portfolio: Pharma, Biotech, AgriChem, Cosmetic, NFPs and Academia Staff - Over 1000 employees - Experienced team: Project Leaders with 20 or more years’ background in industry - High staff loyalty ensures business continuity = reliable long-term client relations Quality Metrics - >90% percent of business is repeat, with high client satisfaction rating - High quality and regulatory compliance confirmed by regulatory audits (e.g. BfArM, EMA, FDA, ANVISA) - 71 sponsor audits & inspections in 2022 SERVICE PORTFOLIO Drug Discovery R&D Services - Assay development & screening - Medicinal and computational chemistry - In vitro biology - In vivo pharmacology - DMPK & toxicology - Next generation (NGS) and single cell sequencing - Biomarker Discovery Analytical Labs - Nonclinical & clinical PK/TK analysis - Immunogenicity & biomarkers - Central lab services Non-Clinical Studies - DMPK in discovery & development - In vitro & in vivo PK studies - Isotope/radiolabeling CMC Services - Route scouting, process development, non-GMP and GMP manufacturing - Analytical testing - Impurity ID, isolation or synthesis - QP services - Clinical trial supply - Formulation support Clinical Trials - In-house phase I/IIa - Multicenter trial management - Monitoring Complementary & Standalone Services - Consultancy - Data management - Data sciences - Medical writing - PK analysis

2400 Route Des Colles Biot, 06410 FranceNUVISAN IN A NUTSHELL Introduction - NUVISAN is a fully integrated contract research organization "from molecule to patient" - Nearly four decades as one of Germany’s first CROs (est. 1979) - Capabilities distributed across five locations in Germany and France - Balanced client portfolio: Pharma, Biotech, AgriChem, Cosmetic, NFPs and Academia Staff - Over 1000 employees - Experienced team: Project Leaders with 20 or more years’ background in industry - High staff loyalty ensures business continuity = reliable long-term client relations Quality Metrics - >90% percent of business is repeat, with high client satisfaction rating - High quality and regulatory compliance confirmed by regulatory audits (e.g. BfArM, EMA, FDA, ANVISA) - 71 sponsor audits & inspections in 2022 SERVICE PORTFOLIO Drug Discovery R&D Services - Assay development & screening - Medicinal and computational chemistry - In vitro biology - In vivo pharmacology - DMPK & toxicology - Next generation (NGS) and single cell sequencing - Biomarker Discovery Analytical Labs - Nonclinical & clinical PK/TK analysis - Immunogenicity & biomarkers - Central lab services Non-Clinical Studies - DMPK in discovery & development - In vitro & in vivo PK studies - Isotope/radiolabeling CMC Services - Route scouting, process development, non-GMP and GMP manufacturing - Analytical testing - Impurity ID, isolation or synthesis - QP services - Clinical trial supply - Formulation support Clinical Trials - In-house phase I/IIa - Multicenter trial management - Monitoring Complementary & Standalone Services - Consultancy - Data management - Data sciences - Medical writing - PK analysis

2400 Route des Colles 2400, route des Colles Biot, Provence-Alpes-Côte d'Azur, 06410 FranceNUVISAN IN A NUTSHELL Introduction - NUVISAN is a fully integrated contract research organization "from molecule to patient" - Nearly four decades as one of Germany’s first CROs (est. 1979) - Capabilities distributed across five locations in Germany and France - Balanced client portfolio: Pharma, Biotech, AgriChem, Cosmetic, NFPs and Academia Staff - Over 1000 employees - Experienced team: Project Leaders with 20 or more years’ background in industry - High staff loyalty ensures business continuity = reliable long-term client relations Quality Metrics - >90% percent of business is repeat, with high client satisfaction rating - High quality and regulatory compliance confirmed by regulatory audits (e.g. BfArM, EMA, FDA, ANVISA) - 71 sponsor audits & inspections in 2022 SERVICE PORTFOLIO Drug Discovery R&D Services - Assay development & screening - Medicinal and computational chemistry - In vitro biology - In vivo pharmacology - DMPK & toxicology - Next generation (NGS) and single cell sequencing - Biomarker Discovery Analytical Labs - Nonclinical & clinical PK/TK analysis - Immunogenicity & biomarkers - Central lab services Non-Clinical Studies - DMPK in discovery & development - In vitro & in vivo PK studies - Isotope/radiolabeling CMC Services - Route scouting, process development, non-GMP and GMP manufacturing - Analytical testing - Impurity ID, isolation or synthesis - QP services - Clinical trial supply - Formulation support Clinical Trials - In-house phase I/IIa - Multicenter trial management - Monitoring Complementary & Standalone Services - Consultancy - Data management - Data sciences - Medical writing - PK analysis

GrasseBiotech 45 Boulevard Marcel Pagnol Grasse, 06130 FrancePhenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models and bioassays for the dermo-cosmetic and pharmaceutical industry through the Noble Prize-winnning technology of iPSC. We specialize in dermatology and ophthalmology, with specific bioassays for skin pigmentation, acne (hyper seborrhea), skin dryness (hypo seborrhea), CBD testing and inflammation, and for diseases that involve retinal degeneration. Phenocell is here to help you improve and accelerate your research and discovery programs with highly relevant in vitro tools.

45 Boulevard Pagnol Grasse Biotech Grasse, Choisir une province, 06130 FrancePKDERM is a French private company that provides smart innovative solutions for in vitro safety and efficacy testing. Created in 2018, PKDERM relies on the expertise of more than 20 years of its founder, Dr. Hanan Osman-Ponchet. As a former leader in metabolism and pharmacokinetics for large pharmaceutical companies, PKDERM’s CEO has developed and tested many alternatives to animal experiment models allowing a reliable and secure evolution from in-vivo experimentation to in-vitro experimentation. The company is located in Grasse, in the south of France and aims to support partners in the area of cosmetics/Personal care, dermatology, pharmaceutical, chemical, agro/petrochamical, and medical device industries. At PKDERM, we are familiar with an array of different assay systems to evaluate the safety and efficacy of new products. This allows us to work with our clients to determine the optimum assay that best fit their needs. Our acknowledged experience with our worldwide network of multidisciplinary partners enable us to rapidly support our customers confronted with new urgent testing needs. Our biological models include but not limited to: 2D culture of human skin cells (keratinocytes, fibroblasts, melanocytes), 3D human skin equivalent models, excised human skin, 2D and 3D human hepatocytes, 2D and 3D human lung models. Our in vitro safety testing includes but not limited to: dermal absorption, skin irritation, eye irritation, skin sensitization, cytotoxicity, phototoxicity, endocrine properties, metabolism, drug transporters and drug-drug interactions. Our in vitro pharmacology/efficacy testing includes but not limited to: dermal and nail absorption, anti-inflammatory properties, pigmentation, ageing, wound healing, ... We provide personalized service for every client and every project and we support the development of new products from the initial reflection and conceptualization to the data promotion and publication. We perform standard testing services as well as optimizing and validating new alternative assays. On the other hand, PKDERM offers scientific and project management services related to alternative methods to animal testing and provides workshops and practical training on the use of in vitro methods. Please do not hesitate to contact us if you need further assistance, have questions or need to place an order.

28, Corniche Valmare Antibes, 06600 FrancePKDERM is a French private company that provides smart innovative solutions for in vitro safety and efficacy testing. Created in 2018, PKDERM relies on the expertise of more than 20 years of its founder, Dr. Hanan Osman-Ponchet. As a former leader in metabolism and pharmacokinetics for large pharmaceutical companies, PKDERM’s CEO has developed and tested many alternatives to animal experiment models allowing a reliable and secure evolution from in-vivo experimentation to in-vitro experimentation. The company is located in Grasse, in the south of France and aims to support partners in the area of cosmetics/Personal care, dermatology, pharmaceutical, chemical, agro/petrochamical, and medical device industries. At PKDERM, we are familiar with an array of different assay systems to evaluate the safety and efficacy of new products. This allows us to work with our clients to determine the optimum assay that best fit their needs. Our acknowledged experience with our worldwide network of multidisciplinary partners enable us to rapidly support our customers confronted with new urgent testing needs. Our biological models include but not limited to: 2D culture of human skin cells (keratinocytes, fibroblasts, melanocytes), 3D human skin equivalent models, excised human skin, 2D and 3D human hepatocytes, 2D and 3D human lung models. Our in vitro safety testing includes but not limited to: dermal absorption, skin irritation, eye irritation, skin sensitization, cytotoxicity, phototoxicity, endocrine properties, metabolism, drug transporters and drug-drug interactions. Our in vitro pharmacology/efficacy testing includes but not limited to: dermal and nail absorption, anti-inflammatory properties, pigmentation, ageing, wound healing, ... We provide personalized service for every client and every project and we support the development of new products from the initial reflection and conceptualization to the data promotion and publication. We perform standard testing services as well as optimizing and validating new alternative assays. On the other hand, PKDERM offers scientific and project management services related to alternative methods to animal testing and provides workshops and practical training on the use of in vitro methods. Please do not hesitate to contact us if you need further assistance, have questions or need to place an order.

CPCAD, Hôpital Archet 2 – Niveau -1 151 route de Saint-Antoine France, Nice, 06200 FranceQIMA Skinpharma is a specialized dermatology clinical research center based in Nice, dedicated to early-phase studies for topical drugs, medical devices, dermo-cosmetics, and nutraceuticals. With expertise in photobiology, imaging technologies, and customized clinical protocols, the center conducts innovative trials focused on skin health, aging, pigmentation, hydration, inflammation, hair growth, and scalp disorders. Supported by experienced dermatologists and a qualified volunteer database, QIMA Skinpharma ensures scientific rigor, high-quality data generation, and a smooth participant experience—from informed consent to follow-up. The center also manages combined aesthetic procedures such as lasers and injections when required by study design. As part of QIMA Life Sciences, QIMA Skinpharma integrates seamlessly into a broader ecosystem covering in vitro, ex-vivo, and clinical evaluation—offering pharma, medical device, and cosmetic industries a complete and agile solution across the entire skin and hair value chain.

45, rue Saint-Philippe - 06000 - NICESkinEthic Laboratories offers in vitro and in vivo skin model services.

2720 chemin saint Bernard Vallauris, 06220 FranceSterlab is specialized in the field of sterilization and medical devices : steam sterilization with the production of chemicals indicators and electronics indicators, Ethylene oxide sterilization, microbiology and chemistry laboratories, robotic and tissue engineering.